ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04340	Hedgehog signaling pathway	2/2	58/7206	6.36758287834e-05
ko05216	Thyroid cancer	1/2	34/7206	0.00941497013743
ko05219	Bladder cancer	1/2	48/7206	0.0132787793657
ko05416	Viral myocarditis	1/2	55/7206	0.015207852659
ko05213	Endometrial cancer	1/2	62/7206	0.0171350384049
ko05221	Acute myeloid leukemia	1/2	63/7206	0.017410196569
ko05223	Non-small cell lung cancer	1/2	66/7206	0.0182354399325
ko04115	p53 signaling pathway	1/2	74/7206	0.0204343939616
ko05214	Glioma	1/2	79/7206	0.0218074882852
ko05212	Pancreatic cancer	1/2	83/7206	0.0229052703599
ko05220	Chronic myeloid leukemia	1/2	85/7206	0.0234539302686
ko05218	Melanoma	1/2	85/7206	0.0234539302686
ko05210	Colorectal cancer	1/2	86/7206	0.0237282024407
ko04917	Prolactin signaling pathway	1/2	87/7206	0.0240024360918
ko05222	Small cell lung cancer	1/2	89/7206	0.0245507878297
ko05215	Prostate cancer	1/2	111/7206	0.0305724873041
ko05162	Measles	1/2	120/7206	0.033030536085
ko01522	Endocrine resistance	1/2	124/7206	0.0341220006542
ko04630	Jak-STAT signaling pathway	1/2	132/7206	0.0363030807665
ko04933	AGE-RAGE signaling pathway in diabetic complications	1/2	135/7206	0.0371203502055
ko04919	Thyroid hormone signaling pathway	1/2	143/7206	0.0392980404373
ko04110	Cell cycle	1/2	145/7206	0.0398420777816
ko04152	AMPK signaling pathway	1/2	161/7206	0.0441888294573
ko04068	FoxO signaling pathway	1/2	167/7206	0.0458163189254
ko05161	Hepatitis B	1/2	173/7206	0.0474424216231
ko05224	Breast cancer	1/2	174/7206	0.0477133039156
ko05206	MicroRNAs in cancer	1/2	177/7206	0.0485257196617
ko04371	Apelin signaling pathway	1/2	177/7206	0.0485257196617
ko04218	Cellular senescence	1/2	177/7206	0.0485257196617
ko04310	Wnt signaling pathway	1/2	181/7206	0.0496084013579